Short answer · Medically reviewed summary · Last updated: 2026-05-08
Appendix cancer is coded under ICD-10 as C18.1 (Malignant neoplasm of appendix) and under ICD-9 as 153.5 (Malignant neoplasm of appendix). These standardized codes are essential for medical billing, insurance authorization, and clinical documentation for patients navigating this rare diagnosis. What is the clinical significance of Appendix Cancer coding? Because Appendix Cancer is a rare malignancy, accurate coding is vital for ensuring patients receive appropriate care and access to specialized treatments.
ICD10 code of Appendix Cancer and ICD9 code
ICD-10 and ICD-9 codes for Appendix Cancer, with classification details for clinicians, coders and patients.
Appendix cancer is coded under ICD-10 as C18.1 (Malignant neoplasm of appendix) and under ICD-9 as 153.5 (Malignant neoplasm of appendix). These standardized codes are essential for medical billing, insurance authorization, and clinical documentation for patients navigating this rare diagnosis.
What is the clinical significance of Appendix Cancer coding?
Because Appendix Cancer is a rare malignancy, accurate coding is vital for ensuring patients receive appropriate care and access to specialized treatments. Using the correct ICD-10 C18.1 code helps oncologists and surgeons track the specific tumor type, which is critical given the disease's heterogeneous nature, ranging from low-grade neuroendocrine tumors to high-grade mucinous adenocarcinomas. Proper coding supports the coordination of care between specialists at centers of excellence.
How is Appendix Cancer typically categorized?
Appendix Cancer is generally categorized based on the histological type of the tumor, which dictates both prognosis and treatment pathways. Clinicians often use the following classifications to guide management:
- Neuroendocrine Tumors (Carcinoid): The most common type, often discovered incidentally during appendectomy.
- Mucinous Adenocarcinoma: Often associated with the development of pseudomyxoma peritonei (PMP).
- Goblet Cell Adenocarcinoma: A rare, aggressive subtype requiring specialized oncological protocols.
- Signet Ring Cell Carcinoma: A rare and often more aggressive form of Appendix Cancer.
Is Appendix Cancer common?
Appendix Cancer is extremely rare, with an estimated incidence of approximately 1 to 2 cases per 1 million people per year. Within the DiseaseMaps.org community, 139 people with Appendix Cancer have joined to share their experiences and support one another. Due to its rarity, patients are often encouraged to seek care from oncologists who specialize in peritoneal surface malignancies.
How does the diagnosis of Appendix Cancer affect treatment planning?
The diagnosis of Appendix Cancer requires a multidisciplinary approach. Treatment often involves surgical debulking and, in specific cases, Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Because Appendix Cancer can present with vague abdominal symptoms, early detection remains a significant clinical challenge.
Next steps
- Consult with a surgical oncologist who specializes in appendiceal malignancies or peritoneal surface diseases.
- Request a referral to a high-volume center that has experience managing the specific histological subtype of your Appendix Cancer.
- Join the 139 members of the DiseaseMaps.org community to connect with others navigating similar treatment journeys.
- Maintain a detailed copy of your pathology reports, as these are essential for clinical trials and second opinions.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with your healthcare provider regarding your specific medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Appendix Cancer.
- Orphanet: Malignant neoplasm of the appendix.
- National Cancer Institute (NCI): Appendiceal Cancer Treatment (PDQ®).
- DiseaseMaps.org: Patient community data for Appendix Cancer.
